Therapeutic Asset Ratings

1,537 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Cyclophosphamide Metastatic Uveal Melanoma	Beijing Biotech	P2/3	BB (70)
Cyclophosphamide Myeloid Leukemia	Actinium Pharmaceuticals	P2/3	BB (70)
ENFORTUMAB VEDOTIN (fully human monoclonal antibody conjugated to a cytotoxic agent monomethyl auristatin E (MMAE) targeting nectin-4) Metastatic Urothelial Carcinoma	Vasgene Therapeutics, Inc	P2/3	BB (70)
FILGRASTIM Diamond-Blackfan Anemia	Paul Szabolcs	P2/3	BB (70)
Fludarabine Thalassemia	Memorial Sloan Kettering Cancer Center	P2/3	BB (70)
Idarubicine Secondary Acute Myeloid Leukemia	Fred Hutchinson Cancer Center	P2/3	BB (70)
Inno-206 Grade 3b Follicular Lymphoma	Merck Sharp & Dohme LLC	P2/3	BB (70)
Irinotecan Islet Cell Tumor	M.D. Anderson Cancer Center	P2/3	BB (70)
Naltrexone Migraine With or Without Aura	Allodynic Therapeutics, Inc	P2/3	BB (70)
Olaparib Ovarian Serous Adenocarcinoma	National Cancer Institute (NCI)	P2/3	BB (70)
Romidepsin Fanconi Anemia	Masonic Cancer Center, University of Minnesota	P2/3	BB (70)
(+)-VINCRISTINE Anaplastic Astrocytoma	Novartis Pharmaceuticals	P2/3	BB (70)
(+)-VINCRISTINE Metastatic Cancer	Incyte Corporation	P2/3	BB (70)
VINCRISTINE SULFATE High Grade B-Cell Lymphoma, Not Otherwise Specified	National Cancer Institute (NCI)	P2/3	BB (70)
Busulphan Bone Marrow Failure	Memorial Sloan Kettering Cancer Center	P2/3	BB (69)
ETOPOSIDE Acute Biphenotypic Leukemia	Federal Research Institute of Pediatric Hematology, Oncology and Immunology	P2/3	BB (69)
Fludarabine Acute Leukemia	Sawa Ito, MD	P2/3	BB (69)
Fludarabine Severe Combined Immunodeficiency	National Institute of Allergy and Infectious Diseases (NIAID)	P2/3	BB (69)
FLUDEOXYGLUCOSE Cancer Of Prostate	Jonsson Comprehensive Cancer Center	P2/3	BB (69)
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER Bone Marrow Failure	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P2/3	BB (69)
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER Fanconi Anemia	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P2/3	BB (69)
Irinotecan Recurrent Adult Lymphoblastic Lymphoma	St. Jude Children's Research Hospital	P2/3	BB (69)
Pentoxifylline Neuralgia Peripheral	Tanta University	P2/3	BB (69)
Ponsegromab Cachexia	Pfizer	P2/3	BB (69)
Rapamycin Acute Myeloid Leukemia, High Risk	Federal Research Institute of Pediatric Hematology, Oncology and Immunology	P2/3	BB (69)

Showing 51 to 75 of 1,537 assets

PreviousPage 3 of 62Next